Citadel Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $90.6M | Buy |
1,494,234
+471,773
| +46% | +$27.5M | 0.01% | 884 |
|
|
2025
Q4 | $55.2M | Sell |
1,022,461
-1,410,082
| -58% | -$67.8M | 0.01% | 1326 |
|
|
2025
Q3 | $110M | Buy |
2,432,543
+1,553,792
| +177% | +$72.6M | 0.02% | 771 |
|
|
2025
Q2 | $40.7M | Buy |
878,751
+592,598
| +207% | +$29.1M | 0.01% | 1403 |
|
|
2025
Q1 | $17.5M | Buy |
286,153
+244,614
| +589% | +$14.3M | ﹤0.01% | 2192 |
|
|
2024
Q4 | $454K | Sell |
41,539
-5,044,596
| -99% | -$282M | ﹤0.01% | 8770 |
|
|
2024
Q3 | $263M | Sell |
5,086,135
-5,885,542
| -54% | -$276M | 0.05% | 280 |
|
|
2024
Q2 | $456M | Buy |
10,971,677
+10,660,102
| +3,421% | +$477M | 0.09% | 136 |
|
|
2024
Q1 | $16.9M | Sell |
311,575
-2,674,467
| -90% | -$136M | ﹤0.01% | 2263 |
|
|
2023
Q4 | $153M | Buy |
2,986,042
+2,125,298
| +247% | +$112M | 0.03% | 464 |
|
|
2023
Q3 | $50M | Sell |
860,744
-327,865
| -28% | -$20.1M | 0.01% | 1075 |
|
|
2023
Q2 | $76M | Buy |
1,188,609
+819,242
| +222% | +$54.9M | 0.02% | 774 |
|
|
2023
Q1 | $25.6M | Sell |
369,367
-2,710,185
| -88% | -$191M | 0.01% | 1681 |
|
|
2022
Q4 | $222M | Buy |
3,079,552
+2,857,109
| +1,284% | +$215M | 0.05% | 300 |
|
|
2022
Q3 | $15.8M | Sell |
222,443
-758,746
| -77% | -$55M | ﹤0.01% | 2155 |
|
|
2022
Q2 | $75.6M | Buy |
981,189
+584,567
| +147% | +$44.5M | 0.02% | 748 |
|
|
2022
Q1 | $29M | Sell |
396,622
-254,136
| -39% | -$17.1M | 0.01% | 1588 |
|
|
2021
Q4 | $40.6M | Sell |
650,758
-76,301
| -10% | -$4.48M | 0.01% | 1336 |
|
|
2021
Q3 | $43M | Sell |
727,059
-1,332,962
| -65% | -$87.8M | 0.01% | 1252 |
|
|
2021
Q2 | $138M | Sell |
2,060,021
-282,516
| -12% | -$18.4M | 0.03% | 505 |
|
|
2021
Q1 | $148M | Buy |
2,342,537
+2,232,421
| +2,027% | +$139M | 0.04% | 410 |
|
|
2020
Q4 | $6.83M | Sell |
110,116
-6,995,645
| -98% | -$430M | ﹤0.01% | 3160 |
|
|
2020
Q3 | $428M | Buy |
7,105,761
+1,081,490
| +18% | +$65.1M | 0.12% | 83 |
|
|
2020
Q2 | $354M | Buy |
6,024,271
+4,703,377
| +356% | +$281M | 0.13% | 78 |
|
|
2020
Q1 | $73.6M | Sell |
1,320,894
-1,459,837
| -52% | -$89.2M | 0.03% | 468 |
|
|
2019
Q4 | $178M | Buy |
2,780,731
+1,767,691
| +174% | +$101M | 0.08% | 201 |
|
|
2019
Q3 | $51.4M | Sell |
1,013,040
-3,376,244
| -77% | -$159M | 0.02% | 743 |
|
|
2019
Q2 | $199M | Buy |
4,389,284
+1,311,875
| +43% | +$61.1M | 0.09% | 165 |
|
|
2019
Q1 | $147M | Buy |
3,077,409
+1,021,015
| +50% | +$50.9M | 0.07% | 234 |
|
|
2018
Q4 | $107M | Sell |
2,056,394
-2,022,021
| -50% | -$109M | 0.06% | 303 |
|
|
2018
Q3 | $253M | Sell |
4,078,415
-84,614
| -2% | -$5.02M | 0.11% | 125 |
|
|
2018
Q2 | $230M | Sell |
4,163,029
-216,798
| -5% | -$11.7M | 0.11% | 122 |
|
|
2018
Q1 | $277M | Sell |
4,379,827
-1,487,119
| -25% | -$95.7M | 0.15% | 81 |
|
|
2017
Q4 | $360M | Buy |
5,866,946
+3,745,139
| +177% | +$234M | 0.22% | 54 |
|
|
2017
Q3 | $135M | Sell |
2,121,807
-119,553
| -5% | -$6.98M | 0.1% | 164 |
|
|
2017
Q2 | $125M | Buy |
2,241,360
+1,368,028
| +157% | +$74.4M | 0.11% | 170 |
|
|
2017
Q1 | $47.5M | Sell |
873,332
-105,605
| -11% | -$5.79M | 0.04% | 482 |
|
|
2016
Q4 | $57.2M | Sell |
978,937
-860,893
| -47% | -$47.1M | 0.06% | 330 |
|
|
2016
Q3 | $99.2M | Sell |
1,839,830
-2,466,371
| -57% | -$158M | 0.1% | 167 |
|
|
2016
Q2 | $317M | Sell |
4,306,201
-714,254
| -14% | -$50.5M | 0.35% | 29 |
|
|
2016
Q1 | $321M | Buy |
5,020,455
+478,740
| +11% | +$30.2M | 0.4% | 22 |
|
|
2015
Q4 | $312M | Sell |
4,541,715
-2,510,092
| -36% | -$166M | 0.34% | 31 |
|
|
2015
Q3 | $417M | Buy |
7,051,807
+3,074,227
| +77% | +$195M | 0.4% | 23 |
|
|
2015
Q2 | $265M | Sell |
3,977,580
-164,624
| -4% | -$10.8M | 0.23% | 61 |
|
|
2015
Q1 | $267M | Buy |
4,142,204
+3,238,388
| +358% | +$203M | 0.25% | 56 |
|
|
2014
Q4 | $53.4M | Buy |
903,816
+363,093
| +67% | +$20.5M | 0.05% | 442 |
|
|
2014
Q3 | $27.7M | Sell |
540,723
-1,280,718
| -70% | -$64M | 0.03% | 720 |
|
|
2014
Q2 | $88.4M | Sell |
1,821,441
-1,456,553
| -44% | -$71.8M | 0.1% | 194 |
|
|
2014
Q1 | $170M | Sell |
3,277,994
-2,897,873
| -47% | -$154M | 0.2% | 69 |
|
|
2013
Q4 | $328M | Buy |
6,175,867
+6,170,686
| +119,102% | +$314M | 0.43% | 14 |
|
|
2013
Q3 | $240K | Sell |
5,181
-595,905
| -99% | -$26.2M | ﹤0.01% | 4584 |
|
|
2013
Q2 | $26.9M | Buy |
+601,086
| New | +$26.1M | 0.05% | 494 |
|
Other funds holding BMY
VCM
VPM
Citadel Advisors's BMY Position: Q1 2026 in Review
Citadel Advisors increased its Bristol-Myers Squibb (BMY) stake by 46% in Q1 2026, buying an estimated $27.5M and bringing the position to 1,494,234 shares worth $90.6M. The position accounts for 0.01% of the portfolio, ranked #884.
Citadel Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $456M in Q2 2024. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Citadel Advisors held 1,494,234 shares of Bristol-Myers Squibb worth $90.6M as of Q1 2026.
- Citadel Advisors bought 471,773 Bristol-Myers Squibb shares in Q1 2026, an estimated $27.5M.
- Bristol-Myers Squibb made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #884 holding.
- Citadel Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Bristol-Myers Squibb position peaked at $456M in Q2 2024.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.